Plandai Biotechnology (Plandai Biotechnology) Inventory-to-Revenue : 0.00 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Plandai Biotechnology Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Plandai Biotechnology's Average Total Inventories for the quarter that ended in Jun. 2023 was $0.00 Mil. Plandai Biotechnology's Revenue for the six months ended in Jun. 2023 was $0.00 Mil.

Plandai Biotechnology's Inventory-to-Revenue for the quarter that ended in Jun. 2023 stayed the same from Jun. 2022 (0.00) to Jun. 2022 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Plandai Biotechnology Inventory-to-Revenue Historical Data

The historical data trend for Plandai Biotechnology's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plandai Biotechnology Inventory-to-Revenue Chart

Plandai Biotechnology Annual Data

Trend

Mar09

Mar10

Mar11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun22

Jun23

Inventory-to-Revenue

Get a 7-Day Free Trial

0.02

0.03

0.11

Plandai Biotechnology Semi-Annual Data
	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun22	Jun23
Inventory-to-Revenue	Get a 7-Day Free Trial											0.02	0.03	0.11	-	-

Competitive Comparison of Plandai Biotechnology's Inventory-to-Revenue

For the Shell Companies subindustry, Plandai Biotechnology's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Plandai Biotechnology's Inventory-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Plandai Biotechnology's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Plandai Biotechnology's Inventory-to-Revenue falls into.

Plandai Biotechnology Inventory-to-Revenue Calculation

Plandai Biotechnology's Inventory-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

	Inventory-to-Revenue (A: Jun. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Jun. 2022 )	+	Total Inventories (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=	N/A

Plandai Biotechnology's Inventory-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

	Inventory-to-Revenue (Q: Jun. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Jun. 2022 )	+	Total Inventories (Q: Jun. 2023 ))	/	count )	/	Revenue (Q: Jun. 2023 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=

Plandai Biotechnology (OTCPK:PLPL) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Plandai Biotechnology's Days Inventory for the six months ended in Jun. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jun. 2023 )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
	=	0	/	0	*	365 / 2
	=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Plandai Biotechnology's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jun. 2023 )	/	Average Total Inventories (Q: Jun. 2023 )
	=	0	/	0
	=

Plandai Biotechnology Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Plandai Biotechnology's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Plandai Biotechnology (Plandai Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Plandai Biotechnology Inc (OTCPK:PLPL) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

4811 49th Street, San Diego, CA, USA, 92115

Website

http://www.plandaibiotech.com

Plandai Biotechnology Inc. manufactures highly bioavailable extracts from live plant materials.

Executives

Callum Baylis-duffield	director	FLAT 37 ISLAND HOUSE THREE MILL LANE, LONDON ENGLAND X0 E33AF
Timothy Matula	other: Former Director	175 JACKSON AVE N, SUITE 102, MINNEAPOLIS MN 55343
Brian Johnson	director	P.O. BOX 1594, FERNDALE WA 98248-1594
Roger Duffield	director, officer: President, Secretary and CFO	2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
Daron Baylis Duffield	director	2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
David Rzepnicki	director	21 HORIZON DRIVE, SARATOGA SPRINGS NY 12866